Laurin Louis-Philippe, Harrak Hind, Elftouh Naoual, Ouimet Denis, Vallée Michel, Lafrance Jean-Philippe
Nephrology Division and Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; and.
Clin J Am Soc Nephrol. 2015 May 7;10(5):817-24. doi: 10.2215/CJN.09210914. Epub 2015 Mar 27.
Peritoneal dialysis (PD) is associated with an increased risk of infection-related hospitalization (IRH) compared with hemodialysis. The objective of this study was to compare mortality and overall readmission after an IRH between PD and hemodialysis.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This propensity score-matched retrospective cohort study assessed patients undergoing long-term dialysis patients, derived from the Canadian Organ Replacement Register and Régie de l'assurance maladie du Québec, who had at least one IRH between January 2001 and December 2007. Patients were followed until death, kidney transplantation, or end of the study period. To estimate the probability of receiving PD versus hemodialysis, propensity scores were obtained using multivariable logistic regression. Mortality and overall readmission risks after the initial IRH were compared using a Cox survival model.
A total of 354 pairs of patients who had at least one IRH were matched for propensity score. During follow-up (median, 1.25 years), 138 hemodialysis patients (24.7/100 patient-years; 95% confidence interval [95% CI], 20.7 to 29.1) and 130 PD patients (21.2/100 patient-years; 95% CI, 17.7 to 25.1) died; 265 hemodialysis patients (144.6/100 patient-years; 95% CI, 127.7 to 163.1) and 299 PD patients (173.2/100 patient-years; 95% CI, 154.1 to 194.0) were readmitted for any cause; and 121 hemodialysis patients (29.7/100 patient-years; 95% CI, 24.7 to 35.5) and 168 PD patients (44.7/100 patient-years; 95% CI, 38.2 to 52.0) were readmitted for an infection. Compared with hemodialysis, PD was not associated with a different mortality risk after an IRH (hazard ratio [HR], 0.87; 95% CI, 0.69 to 1.11). PD was associated with a higher risk of infection-related overall readmission compared with hemodialysis (HR, 1.44; 95% CI, 1.14 to 1.81), but not with the risk of all-cause overall readmission (HR, 1.15; 95% CI, 0.98 to 1.36).
PD was not associated with higher mortality or all-cause overall readmission following an IRH compared with hemodialysis, but PD patients were at higher risk of infection-related overall readmission after IRH. IRHs are associated with significant mortality and overall readmissions. Evaluation of strategies to reduce infections in both hemodialysis and PD recipients are needed to improve patient care and outcomes.
与血液透析相比,腹膜透析(PD)与感染相关住院(IRH)风险增加有关。本研究的目的是比较PD和血液透析患者发生IRH后的死亡率和再次入院率。
设计、地点、参与者及测量方法:这项倾向评分匹配的回顾性队列研究评估了长期透析患者,数据来源于加拿大器官替代登记处和魁北克省医疗保险局,这些患者在2001年1月至2007年12月期间至少发生过一次IRH。对患者进行随访直至死亡、肾移植或研究期结束。为了估计接受PD与血液透析的概率,使用多变量逻辑回归获得倾向评分。使用Cox生存模型比较初次IRH后的死亡率和再次入院风险。
共有354对至少发生过一次IRH的患者进行了倾向评分匹配。在随访期间(中位数为1.25年),138名血液透析患者(24.7/100患者年;95%置信区间[95%CI],20.7至29.1)和130名PD患者(21.2/100患者年;95%CI,17.7至25.1)死亡;265名血液透析患者(144.6/100患者年;95%CI,127.7至163.1)和299名PD患者(173.2/100患者年;95%CI,154.1至194.0)因任何原因再次入院;121名血液透析患者(29.7/100患者年;95%CI,24.7至35.5)和168名PD患者(44.7/100患者年;95%CI,38.2至52.0)因感染再次入院。与血液透析相比,PD患者发生IRH后的死亡风险无差异(风险比[HR],0.87;95%CI,0.69至1.11)。与血液透析相比,PD患者感染相关的再次入院风险更高(HR,1.44;95%CI,1.14至1.81),但与全因再次入院风险无关(HR,1.